MHRA
- Status: likely_approved
🇬🇧 Chrft5 in United Kingdom
Chrft5 (BASILIXIMAB) regulatory status in United Kingdom.
Marketing authorisation
Chrft5 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United Kingdom
Frequently asked questions
Is Chrft5 approved in United Kingdom?
Yes. MHRA has authorised it.
Who is the marketing authorisation holder for Chrft5 in United Kingdom?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.